BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8272248)

  • 21. Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial.
    Ingram AJ; Parbtani A; Churchill DN
    Nephrol Dial Transplant; 1998 Jun; 13(6):1452-7. PubMed ID: 9641175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of dialyzers used in shortened dialysis.
    Petersen J; Ramsey KD; Kang MS; Yeh IT
    ASAIO Trans; 1989; 35(3):338-40. PubMed ID: 2688714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new polymethylmethacrylate membrane for hemodialysis.
    Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
    Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behaviour of platelets and beta-thromboglobulin.
    Ivanovich P; Hammerschmidt DE; Quintanilla A; Kishimoto T; Tanaka H; Levin N; Klinkmann H
    Nephrol Dial Transplant; 1993; 8 Suppl 2():15-9. PubMed ID: 8272246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypersensitivity reactions to ethylene oxide: clinical experience.
    Masin G; Polenaković M; Ivanovski N; Atanasov N; Olivera S; Cakalaroski K
    Nephrol Dial Transplant; 1991; 6 Suppl 3():50-2. PubMed ID: 1775268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal reuse of cuprammonium rayon hollow-fibre dialyzers.
    Chan MK; Lau N
    Int J Artif Organs; 1989 Apr; 12(4):223-8. PubMed ID: 2656538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility of PMMA membranes used in haemofiltration and haemodiafiltration: beta 2-microglobulin removal and release of granulocyte elastase.
    Hillion D; Haas T; Uzan M; Pertuiset N; Beyne P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():84-5. PubMed ID: 1866076
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of gamma radiation versus ethylene oxide sterilization of dialyzers and blood lines on plasma levels of granulocyte elastase in hemodialyzed patients.
    Hörl WH; Riegel W; Schollmeyer P
    Clin Nephrol; 1985 Nov; 24(5):232-6. PubMed ID: 3852707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction, demography, and general methods.
    Levin N; Zasuwa G; Klinkmann H
    Nephrol Dial Transplant; 1993; 8 Suppl 2():2-7. PubMed ID: 8272247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients.
    Pickett TM; Cruickshank A; Greenwood RN; Taube D; Davenport A; Farrington K
    Blood Purif; 2002; 20(2):161-6. PubMed ID: 11818679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
    Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta 2-microglobulin kinetics during haemofiltration.
    Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
    Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.